Issuu on Google+

Presented at the

May 8, 2013 • 6:30 am – 7:30 am Wynn Las Vegas • Las Vegas, NV

Geoffrey C. Wall, PharmD, FCCP, BCPS, CGP Professor of Clinical Sciences Drake University College of Pharmacy and Health Sciences Internal Medicine Clinical Pharmacist Iowa Methodist Medical Center Des Moines, Iowa

Jeffrey M. Weinberg, MD, FAAD

Associate Clinical Professor of Dermatology Columbia University College of Physicians and Surgeons New York, New York

Sponsored by

This activity is supported by an educational grant from Lilly USA, LLC. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.


Advances in the Management of Psoriasis A Clinical Update for Specialty Pharmacists

3

Geoffrey C. Wall, PharmD, FCCP, BCPS, CGP Professor of Clinical Sciences Drake University College of Pharmacy and Health Sciences Internal Medicine Clinical Pharmacist Iowa Methodist Medical Center Des Moines, Iowa

Geoffrey C. Wall, PharmD, is a Professor in the Department of Clinical Sciences of the College of Pharmacy at Drake University, and Clinical Assistant Professor in the Department of Pharmacology and Physiology at Des Moines University College of Osteopathic Medicine. His clinical practices include the Internal Medicine and Medical Intensive Care Teaching Services at Iowa Methodist Medical Center as well as the Inflammatory Bowel Disease Center in Des Moines. Dr. Wall received his Bachelor of Science in Pharmacy from the University of Utah in 1992 and his Doctor of Pharmacy from Idaho State University in 1998. He completed an American Society of HealthSystem Pharmacists (ASHP)–accredited Internal Medicine Specialty Residency at Scott and White Memorial Hospitals and Clinics in 1999. A certified Geriatric Pharmacist board-certified in Pharmacotherapy, he is a Fellow of the American College of Clinical Pharmacy. Dr. Wall has written peer-reviewed papers and textbook chapters on a variety of topics, and has designed or participated in several clinical trials. His research interests include drug treatment of gastrointestinal disorders, including inflammatory bowel disease (IBD), and clinical evaluation of drug allergy and rheumatologic disorders.

Faculty

Faculty


4

Faculty

Jeffrey M. Weinberg, MD, FAAD Associate Clinical Professor of Dermatology Columbia University College of Physicians and Surgeons New York, New York

Jeffrey M. Weinberg, MD, is an associate clinical professor of dermatology at Columbia University College of Physicians and Surgeons in New York City. In addition, he is director of the Clinical Research Center at St. Luke’s-Roosevelt Hospital Center and acting director of the Division of Dermatology at Jamaica Hospital Medical Center, both in New York City. Dr. Weinberg graduated from the University of Pennsylvania School of Medicine in Philadelphia and completed an internship in medicine at Columbia-Presbyterian Medical Center in New York City. He then completed a residency in dermatology at the University of Pennsylvania School of Medicine. Dr. Weinberg is a Fellow of the American Academy of Dermatology, where he has served on several committees, and a member of the Dermatology Foundation. He is a diplomate of the American Board of Dermatology. Dr. Weinberg is on the editorial board and is a senior editor of Cutis. He is on the international editorial board of the American Journal of Clinical Dermatology and the manuscript review board of Hospital Physician, and is a reviewer of Archives of Dermatology, Pediatric Dermatology, and the American Journal of Clinical Dermatology. His clinical research encompasses a variety of dermatology-related topics, including studies of diagnostic methods in the evaluation of onychomycosis. He has been principal or co-investigator for several clinical trials. In addition, he has written or co-authored numerous articles for professional journals such as Cutis, the Journal of the American Academy of Dermatology, and Blood, as well as reviews, book chapters, and abstracts.


Advances in the Management of Psoriasis A Clinical Update for Specialty Pharmacists

5

Agenda 6:30 am– 6:35 am

Welcome

Jeffrey M. Weinberg, MD, FAAD

6:35 am– 7:00 am

PSORIASIS: Clinical Presentations, Treatment, and Emerging Therapies Jeffrey M. Weinberg, MD, FAAD

 NGOING MANAGEMENT OF O PSORIASIS: Monitoring Patient Responses Geoffrey C. Wall, PharmD, FCCP, BCPS, CGP

7:25 am– 7:30 am

Question and Answer Session

Overview Appropriate consultations with dermatologists and patients allow specialty pharmacists to play central roles in shaping psoriasis therapy, particularly around issues of medical management, patient adherence to treatment plans, and monitoring strategies to examine disease evolution and therapeutic responses. This session will address disease pathophysiology, evidence-based guideline recommendations for moderate-to-severe psoriasis, and emerging biologic treatment options. Expert faculty will share their insights into personalized therapy, patient education, and practical care pathways.

Target Audience This activity is intended for specialty pharmacists involved in the management of patients with psoriasis.

Preamble

7:00 am– 7:25 am


6

Learning Objectives Upon completion of this knowledge activity, participants will be better prepared to: • Discuss the pathogenic mechanisms of psoriasis, including relationships with common comorbidities and treatment strategies • Review the potential benefits and risks of current and emerging treatment strategies for moderate-to-severe psoriasis

Preamble

• Counsel patients with psoriasis on therapeutic options, treatment adherence, and potential adverse effects of pharmacologic therapies

Accreditation MedEDirect is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is approved for 1.0 hours (0.10 CEUs) of continuing education and has been assigned ACPE Universal Activity Number 0498-0000-13-0003-L01-P.

Scientific Integrity and Disclosure of Financial Interests MedEDirect requires that all CE information be based on the application of research findings and the implementation of evidencebased medicine. MedEDirect promotes balance, objectivity, and absence of bias in its content. All persons in position to control the content of this activity must disclose any conflict of interest. MedEDirect has mechanisms in place to resolve all conflicts of interest prior to an educational activity being delivered to the learners. The faculty for this program discloses the following information: Geoffrey C. Wall, PharmD, FCCP, BCPS, CGP, is a consultant to ALK-Abello, Inc. and a member of the speaker’s bureau for Johnson & Johnson and Merck & Co, Inc . Jeffrey M. Weinberg, MD, FAAD, is a member of the speaker’s bureau for Abbott Laboratories, Amgen Inc., and LEO Pharma.


Advances in the Management of Psoriasis A Clinical Update for Specialty Pharmacists

7

Method of participation There are no fees for participating in and receiving credit for this activity. Participants must participate in the session and complete an activity evaluation form.

CME Credit Instructions Claim your CME credit for this activity online by following the instructions below: *Expires: 6/19/2013

1. Go to: www.mededirect.org 2. C  lick on “Click Here to Access Your CME Credit” (you will be directed to the Educational Offerings page) 3. E  nter Activity Code 1028 in “Search for a program by activity code, city, or state:” and press the <enter> key 4. T  he program’s title, date, city, and state will appear. Click on the Title to select it 5. S  ign up for a free account by clicking “Click Here to Sign Up” (or log in if already registered). Click “Continue” 6. Enter Activity Code 1028 and click “Proceed” 7. C  lick on the Program Evaluation, complete it in its entirety and click “Next” 8. Click on “Download certificate(s)”

*Participants will be able to claim credit for 6 weeks after program completion.

Preamble

Event date: 5/8/2013


Slides 8








Advances in the Management of Psoriasis A Clinical Update for Specialty Pharmacists

9

 

Slides




Slides 10








Advances in the Management of Psoriasis A Clinical Update for Specialty Pharmacists

11

 

Slides




Slides 12








Advances in the Management of Psoriasis A Clinical Update for Specialty Pharmacists

13

 

Slides




Slides 14








Advances in the Management of Psoriasis A Clinical Update for Specialty Pharmacists

15

 

Slides




Slides 16








Advances in the Management of Psoriasis A Clinical Update for Specialty Pharmacists

17

 

Slides




Slides 18








Advances in the Management of Psoriasis A Clinical Update for Specialty Pharmacists

19

 

Slides




Slides 20








Advances in the Management of Psoriasis A Clinical Update for Specialty Pharmacists

21

 

Slides




Slides 22








Advances in the Management of Psoriasis A Clinical Update for Specialty Pharmacists

23

 

Slides




Slides 24








Advances in the Management of Psoriasis A Clinical Update for Specialty Pharmacists

25

 

Slides




Slides 26








Advances in the Management of Psoriasis A Clinical Update for Specialty Pharmacists

27

 

Slides




Slides 28








Advances in the Management of Psoriasis A Clinical Update for Specialty Pharmacists

29

 

Slides




30

 

Slides

          


Claim your CE credit for this activity online

www.mededirect.org


Advances in the Management of Psoriasis